Stay updated on Arbaclofen in Children and Adolescents With ASD Clinical Trial
Sign up to get notified when there's something new on the Arbaclofen in Children and Adolescents With ASD Clinical Trial page.

Latest updates to the Arbaclofen in Children and Adolescents With ASD Clinical Trial page
- Check4 days agoChange DetectedFooter now shows Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check33 days agoChange DetectedA note clarifying that PubMed-listed publications are automatically populated from PubMed and may not all relate to the study was added, replacing the previous wording. The revision version label was updated from v3.2.0 to v3.3.1, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedDeleted boilerplate notice about a lapse in government funding and NIH operating status; study details and core content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check55 days agoChange DetectedNo significant changes detected between the two screenshots; the page content and study details remain the same, with only minor formatting differences.SummaryDifference0.4%

- Check83 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference2%

Stay in the know with updates to Arbaclofen in Children and Adolescents With ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arbaclofen in Children and Adolescents With ASD Clinical Trial page.